MedTrace Logo

Serum Interleukin 6 in Chronic Obstructive Pulmonary Disease

NCT05214508 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2022-01-28

No results posted yet for this study

Summary

The aim of this study is to estimate level of IL 6 in COPD patients and its relation to COPD severity and acute exacerbation.

Conditions

  • Chronic Obstr Lung Disease

Interventions

DIAGNOSTIC_TEST

interleukin 6

assessment of serum IL-6 by ELISA

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Laila Anwar Sharawy · Beni Suef faculty of medicine

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2020-11-01
Completion
2020-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05214508 on ClinicalTrials.gov